SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,587 Cr | ₹4,276 Cr | ₹4,567 Cr | ₹4,061 Cr | ₹3,647 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1,587 Cr |
| Mar2025 | ₹4,276 Cr |
| Mar2024 | ₹4,567 Cr |
| Mar2023 | ₹4,061 Cr |
| Mar2022 | ₹3,647 Cr |
How is Contingent Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,587 Cr | -62.88 | |
| Mar2025 | ₹4,276 Cr | -6.38 | |
| Mar2024 | ₹4,567 Cr | 12.46 | |
| Mar2023 | ₹4,061 Cr | 11.36 | |
| Mar2022 | ₹3,647 Cr | - | |
Compare Contingent Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,324.5 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| MANKIND PHARMA | ₹104,275.0 Cr | -0.6% | 6.5% | 7.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% |
8.3% |
15.5% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses